| Nov 12 |
Profound Medical to Participate in the Stifel 2024 Healthcare Conference
|
| Nov 10 |
Profound Medical Corporation (PROF) Q3 2024 Earnings Call Transcript
|
| Nov 9 |
Profound Medical Third Quarter 2024 Earnings: Misses Expectations
|
| Nov 8 |
Profound Medical Corp (PROF) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Rising Expenses
|
| Nov 8 |
Profound Medical reports Q3 results
|
| Nov 7 |
Profound Medical Announces Third Quarter 2024 Financial Results
|
| Nov 4 |
Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025
|
| Oct 17 |
Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference Call to Follow
|
| Oct 16 |
Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer
|
| Oct 12 |
Owning 50% shares,institutional owners seem interested in Profound Medical Corp. (TSE:PRN),
|
